| 250.31 Data as of May 24 | -4.56 / -1.79%Today’s Change | 107.31 Today|||52-Week Range 283.99 | +46.32% Year-to-Date |
The 17 analysts offering 12-month price forecasts for Regeneron Pharmaceuticals Inc have a median target of 290.00, with a high estimate of 315.00 and a low estimate of 225.00. The median estimate represents a +15.86% increase from the last price of 250.31.

The current consensus among 21 polled investment analysts is to Buy stock in Regeneron Pharmaceuticals Inc. This rating has held steady since May, when it was upgraded from a rating.Move your mouse over past
months for detail

Move your mouse over a quarter or year to see how estimates have changed over time.




